medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2022, Number 07

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (07)

Myoma nascens: Clinical case

Montañez MÁ, Higuera-García JS, Vargas-Rodríguez LJ

Language: Spanish
References: 10
Page: 612-615
PDF size: 174.36 Kb.


ABSTRACT

Background: Uterine fibroids are the most frequent gynecologic tumors during reproductive age and extremely rare in preadolescence and early adolescence, representing only 1% of all cases. It is even more exceptional that these cases manifest as myoma prolapse (myoma nascens).
Clinical case: 11-year-old female patient from Tunja, Colombia, height 143 cm, weight 31 kg, BMI 15.15 kg/m2 (risk of thinness by Colombian resolution), with no pathological, pharmacological or surgical history; menarche at 11 years old, without onset of sexual life. She was taken to consultation due to a clinical picture of five hours of evolution, consisting of a mass of approximately 3 cm in diameter, protruding the vagina at the time of defecation, painful on palpation, with scanty bleeding and vaginal discharge. The initial suspicion was possible cervical polyp.
Conclusion: Cases of myoma nascens are, in general, infrequent, even more so in pediatric age. More studies are needed to establish the biological characteristics of this type of lesions in girls and adolescents to indicate the most appropriate treatment. Surgical treatment seems to be the option that has received the most support in other case reports. Follow-up is crucial because the behavior of this type of lesions in this age group is unknown.


REFERENCES

  1. Moroni RM, Vieira CS, Ferriani RA, dos Reis RM, Nogueira AA,Brito LGO. Presentation and treatment of uterine leiomyomain adolescence: a systematic review. BMC Women's Health 2015; 15: 4. doi: 10.1186/s12905-015-0162-9.

  2. Vilos GA, Allaire C, Laberge PY, Leyland N, Vilos AG, MurjiA, Chen I. The management of uterine leiomyomas. JObstet Gynaecol Can 2015; 37 (2): 157-78. doi: 10.1016/S1701-2163(15)30338-8

  3. Kumura ND, Siarezi S. A case of a prolapsed fibroid in a12-year-old girl. J Pediatr Adolesc Gynecol 2020; 33 (1):96-97. doi: 10.1016/j.jpag.2019.08.013

  4. Aydın S, Çelik HG, Maraşlı M, Bakar RZ. Clinical predictorsof successful vaginal myomectomy for prolapsed pedunculateduterine leiomyoma. J Turk Ger Gynecol Assoc 2018;19: 146-50. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085531/pdf/JTGGA-19-146.pdf

  5. Laughlin SK, Schroeder JC, Baird DD. New directions in theepidemiology of uterine fibroids. Semin Reprod Med 2010;28 (3): 204-17. https://doi.org/10.1055/s-0030-1251477

  6. William H, Parker M. Uterine myomas: management. FertilSteril 2007; 88 (2): 255-71. doi: 10.1016/j.fertnstert.2007.06.044

  7. Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO WorkingGroup on Menstrual Disorders. FIGO ClassificationSystem (PALM-COEIN) for causes of abnormal uterinebleeding in nongravid women of reproductive age. Int GynecolObstet 2011; 113 (1): 3-13. https://doi.org/10.1016/j.ijgo.2010.11.011

  8. Di Muro-Mea MA, Berón-Ventimilla JC, Arango-MartínezAM, Serna-Agudelo RE, Castañeda-Roldán JD, de losRíos-Posada JF et al. Miomas submucosos: gran desafíopara el ginecólogo. Rev Obstet Ginecol Venez 2013; 73(2): 122-31. http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0048-77322013000200007&lng=es

  9. Jérome L, Dreyfus M, Bekkari Y. Surgical management duringlabor of giant vaginal fibromyoma. J Gynecol Surgery 2004;20: 1719. https://doi.org/10.1089/104240604323021990.

  10. Donnez J, Vázquez F, Tomaszewski J, Kazem Nouri, PhilippeBouchard, Bart CJM, et al. Long-term treatment of uterinefibroids with ulipristal acetate. Fertil Steril 2014; 101 (6):1565-73.e1-18. doi: 10.1016/j.fertnstert.2014.02.008




2020     |     www.medigraphic.com